Value through Innovation27 July 2016

What is a lay summary?

To view this video in other translations click on the language below:
Chinese (simplified)
Chinese (traditional)
French
German
Italian
Japanese
Portuguese (Brazilian)
Spanish

Clinical Study Results

  • Telmisartan + Ramipril - Healthy
    Clinical Study Number 1236.3
    Study Indication Healthy
    Product Telmisartan + Ramipril
    Generic Name Telmisartan + Ramipril
    Lab Code
    Clinical Phase I
    Study Title

    Influence of food on the bioavailability of 80 mg telmisartan / 10 mg ramipril fixed dose combination in healthy male and female volunteers (an open-label, randomised, single-dose, two-sequence, two-period crossover study)

    Study Document
    Trial synopsis 1236.3_CO english
  • Telmisartan + Ramipril - Healthy
    Clinical Study Number 1236.4
    Study Indication Healthy
    Product Telmisartan + Ramipril
    Generic Name Telmisartan + Ramipril
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of 40 mg telmisartan/ 2.5 mg ramipril fixed-dose combination compared with the mono components, telmisartan and ramipril (two different formulations) given concomitantly to healthy male and female volunteers (an open-label, randomised, single-dose, three-way cross-over study)

    Study Document
    Trial synopsis 1236.4 english
  • Telmisartan + Ramipril - Healthy
    Clinical Study Number 1236.5
    Study Indication Healthy
    Product Telmisartan + Ramipril
    Generic Name Telmisartan + Ramipril
    Lab Code
    Clinical Phase I
    Study Title

    Bioequivalence of 80 mg telmisartan/10 mg ramipril fixed-dose combination compared with the mono components, telmisartan and ramipril (two different formulations) given concomitantly to healthy male and female volunteers (an open-label, randomised, single-dose, three-way crossover study)

    Study Document
    Trial synopsis 1236.5_CO english
  • Telmisartan + Ramipril - Healthy
    Clinical Study Number 1236.6
    Study Indication Healthy
    Product Telmisartan + Ramipril
    Generic Name Telmisartan + Ramipril
    Lab Code
    Clinical Phase I
    Study Title

    Steady state pharmacokinetics of 80 mg telmisartan (Micardis®), 10 mg ramipril (Delix®) or the combination following repeated oral doses to healthy male and female volunteers (an open-label, randomised, multiple-dose, three-way crossover study)

    Study Document
    Trial synopsis 1236.6 english